Molecular Diagnosis of Primary Liver Cancer Using Blood Samples
Author Information
Author(s): Chang Y-C, Ho C-L, Chen Helen H-W, Chang T-T, Lai W-W, Dai Y-C, Lee W-Y, Chow N-H
Primary Institution: National Cheng Kung University Hospital
Hypothesis
Can microsatellite DNA analysis in serum effectively diagnose primary liver cancer?
Conclusion
The study identified a profile of microsatellite markers that can help in the early detection of hepatocellular carcinoma.
Supporting Evidence
- 76.2% of hepatocellular carcinoma patients showed loss of heterozygosity in serum DNA.
- The positive predictive value of the microsatellite markers was 100%.
- 80.8% negative predictive value for hepatocellular carcinoma was achieved.
- Five of seven patients with low alpha-fetoprotein levels had positive serum DNA tests.
Takeaway
Doctors can check for liver cancer by looking at DNA in blood samples, which is easier than doing surgery.
Methodology
The study analyzed serum DNA from patients with primary liver cancer using 109 microsatellite markers.
Potential Biases
Potential bias due to the selection of patients and the reliance on specific genetic markers.
Limitations
The study was limited to a small sample size and focused primarily on hepatocellular carcinoma.
Participant Demographics
Participants included 21 patients with hepatocellular carcinoma, 6 with cholangiocarcinoma, and 27 controls with chronic hepatitis or cirrhosis.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website